Background: The nervous system has been implicated
INTRODUCTION
Substantial evidence indicates a cellular and molecular basis for communication between the nervous system and the immune system (reviewed in Ref. 1 ). In the case of the skin, psoriasis is an autoimmune T cell-mediated disorder characterized by exacerbation in response to stress and displays a striking symmetry in the distribution of lesions which is similar to patterns of innervation (2) . Compounds of neural origin such as substance P and calcitonin-gene related protein (CGRP) have been localized to skin lesions and implicated in the pathogenesis of this disease (3) (4) (5) . Interleukin 12 , a cytokine produced by antigen-presenting cells, has pleiotrophic effects on natural killer (NK) and T cells, including enhancement of cytotoxicity and interferon-y (IFNy) production (6) . In vivo and in vitro, supports the generation of a TH-1 immune response characterized by cell-mediated immunity and delayed-type hypersensitivity (7) .
We were initially interested in examining IL-12 expression in psoriasis, since this disorder is characterized by a cellular immune reaction featuring TH-1 type lymphocytes (8) . Here we report that IL-12 is contained within peripheral nerves, including cutaneous sensory nerve endings in the upper dermis and epidermis of normal and diseased skin samples. In addition, immunoreactivity was observed in neuronal cells of dorsal root and sympathetic ganglion, the surrounding satellite cells, in peripheral nerve axonal processes and Schwann cells of the sciatic, femoral, and sural nerves, and within oligodendroglial cells of the spinal cord. was not identified in anterior horn cells. Identical immunostaining profiles were obtained with different anti-IL- 12 antibodies in both human and rodent tissue samples. Using reverse transcription-polymerase chain reaction (RT-PCR) to detect the inducible-p40 (heavy chain) mRNA of IL-12, transcripts were detected in various rodent tissues including skin, sympathetic ganglion, sciatic and sural nerves, and spinal cord. Examination of purified cell types in culture revealed p40 mRNA production in oligodendroglial cells, microglial cells, and Schwann cells, but not neuronal cells, astrocytes, or fibroblasts. released from these neural cell types needs to be considered as additional non-bone marrow-derived sources of IL-12, and may be important in local inflammatory and immunological responses initiated through exogenous or endogenous neural stimulation.
MATERIALS AND METHODS

Tissue Samples
Punch biopsies of human skin were obtained either from normal, healthy individuals (n = 5) or from untreated lesions of patients with various dermatological disorders including psoriasis (n = 5), challenge phase of allergic contact dermatitis (rhus dermatitis; n = 4), cutaneous T cell lymphoma (CTCL; n = 4). All biopsies were performed after informed consent and approval of the Human Subjects Committee. Samples of human sural nerve, femoral nerve, and spinal cord (n = 3) were obtained from autopsy material within 2 (9) . The Schwann cell population was expanded with 2 mM forskolin and 5 gg/ml of glial growth factor purified from bovine pituitary glands by carboxymethylcellulose chromatography (9) . Schwann cells were used after four to five passages and small glass coverslips (12 mm in diameter) included in the culture dishes to assess the purity of the cell population by indirect immunofluorescence staining as previously described (10) . Schwann cell cultures contained less than 1% contaminating fibroblasts as identified with antibodies to Thy 1.1 (hybridoma TI 1D7e2; American Type Culture Collection, Rockville, MD, U.S.A.). Mitogens were removed from the medium at least 5 days before treatment or harvest.
Conditioned medium was collected from rat Schwann cells which were seeded at a density of 106 cells/10-cm dish. The feeding medium was replaced with 5 ml of serum-free N2 medium (Gibco-BRL, Gaitherburg, MD, U.S.A.) after 24 hr, and the conditioned medium was collected 48 hr later. After centrifugation at 3,000 X g for 5 To obtain oligodendrocytes, fresh medium was added to the flasks and the shaking was continued for 18 hr. The detached cells were preplated on plastic for 20 min and the nonadherent cells were seeded onto poly-lysine-coated dishes. The growth medium was replaced 24 hr later with N2 medium containing 0.5% FBS to promote oligodendrocyte differentiation, and the cultures were maintained for [18] [19] [20] [21] days. The cultures contained .70% oligodendrocytes at harvest, which were identified by staining with anti-galactocerebroside antibodies (Advanced Immunochemicals, Los Angeles, CA, U.S.A.). Nearly all of the contaminating cells were GFAPpositive astrocytes.
The cells remaining in the flask after two successive shake-offs were replated and grown for 7 (13) . PCR reactions were performed as described (13), using specific primers for actin (15) (Fig. 1, arrows) , and within nerves that penetrated the basement membrane zone to reach the epidermal compartment (Fig. 1, inset,  arrowhead) , as well as in larger aggregates of nerve bundles in the mid and deeper dermis (data not shown). Nerve fibers within the pili erector smooth muscle structures could also be visualized as transversing between muscle fibers in a spiraling fashion (Fig. 2) . Occasional areas of epidermal keratinocyte staining for IL-12 was observed, but this was not as consistent or as intense as the staining of the nerve fibers. This keratinocyte staining was judged to be nonspecific since in our previous report p40 IL-12 mRNA could not be detected under any culture condition for human keratinocytes (17) . An (Figs. 3 and 4) . In cross-sections, it was obvious that the axons were IL-12 positive, and the surrounding myelin sheath was completely devoid of any staining. However, the Schwann cells cytoplasm was positive for (Fig. 4, arrows) .
Within dorsal root ganglia, occasional perikaria of the ganglion cells were IL-12 positive (Fig. 5) , whereas other ganglion cells were negative. Satellite cells were diffusely and strongly positive for IL-12 ( Figure 5, inset) . Similar positive and negative immunostaining results for IL-12 were observed for sympathetic ganglia (data not shown). In the spinal cord, oligodendroglial cells were IL-12 positive, but no staining of anterior horn motor neurons or astrocyte cells was observed (Fig. 6) Figure 7 shows a composite RT-PCR result for dilution of splenocyte RNA ranging from 0.25 to 0.0004 ,ug RNA. IL-12 p40 mRNA which was barely detectable in resting splenocytes, increased 50-to 100-fold after Con A stimulation (middle panel). Compared with splenocyte levels, the mouse and rat tissues, as well as cultured rat cell of neural origin, produced less IL-12 p40 mRNA (Fig. 7) . Among mouse tissues, positive IL-12 p40 mRNA signals were observed for sympathetic ganglion, dorsal root ganglion, and spinal cord. In rat tissues, sympathetic ganglion, sciatic nerve, and skin all contained detectable p40 transcripts (Fig. 7, left panels) . IL-12 p40 mRNA was also detected in cultures of rat oligodendrocytes and microglial which was not due to contaminating astrocytes since these cells were negative for this transcript (Fig. 7, right panel) . From (20, 21) . In this report, we observed IL-12 immunoreactivity in neuronal and glial cells, and confirmed that in culture, nonbone marrow-derived glial cells can produce the inducible p40 chain mRNA. At the present time, the function of the IL-12 present either in the skin or at extracutaneous tissue sites is unknown. We can speculate that these neuronal processes and glial-derived sources of IL-12 may serve a reservoir function containing preformed cytokines that can be released rapidly following neurogenic stimulation, and act in a paracrine fashion targeted locally at adjacent immunocompetent cells.
The distribution pattern of mRNA and protein suggest a possible neurotrophic role for IL-12 similar to that for ciliary neurotrophic factor (CNTF) and related hematopoetic cytokines including IL-6 and lymphocyte inhibitory factor (LIF). was localized to neuronal cell bodies and processes, and to myelin-forming glial cells which are in direct contact with neurons. However, mRNA was detected in the glial cells but not neuronal cells in vitro, suggesting that only glial cells synthesize and release IL-12 which might be taken up and transported retrogradely by neurons. Although we have no direct evidence that IL-12 has neurotrophic activity, the presence of IL-12 in subpopulations of sensory and sympathetic neurons in the periphery and large pyramidal cells in the cerebral cortex mark these cells as potential targets. Myelin-forming glia have been previously shown to synthesize CNTF and LIF (22) (23) (24) in addition to a family of neurotrophins (25, 26) . Most of these factors have trophic activity on neurons in sensory and sympathetic ganglia, and may be acting independently on unique subsets of cells or in combination on overlapping cell populations (27) .
The specificity of trophic influence by a particular factor depends not only on the sites of synthesis and release but on the expression of high affinity receptors by the target cells. CNTF, LIF and IL-6 act on neurons via a shared signaling pathway that involves a multicomponent receptor complex (28) gand specificity. The p40 subunit of IL-12 resembles the soluble form of the low-affinity receptors for IL-6 and CNTF, which has led to the concept that IL-12 is produced as a preformed complex between a soluble receptor (p40) and a cytokine (p35). Based on analogy with IL-6/LIF/CNTF, a gpl30-like molecule was predicted to form part of the IL-12 receptor (8). Indeed, a cDNA encoding a molecule with strong homology to gpl30 has recently been cloned (29) . However, binds to this receptor with low affinity and dimerization appears to be ligand independent. An additional protein has been found in association with the gp130-like receptor that could be a subunit required for high-affinity binding and functional activity (30) . Identification of the high-affinity converter for IL-12 receptor is crucial for defining target cell populations for IL-12 both within and outside the nervous system. IL-12, by virtue of its anatomic location in neural tissue, may also participate in immune responses associated with infectious and noninfectious inflammatory disease processes within the nervous system and skin. induces the differentiation of T lymphocytes to T helper 1 cells which initiates cell-mediated immunity (8 (31, 32) . The levels of IL-12 detected in the conditioned medium obtained from the cultured Schwann cells is sufficient to activate a T cell response either to Mycobacterium avium (33) or bacterial-derived superantigen (17) .
In a common T cell-mediated skin disease such as psoriasis, we have recently demonstrated that the cytokine network present in untreated lesions closely resembles the T helper type 1 immunological response (8) . The present finding that cutaneous nerves contain IL-12 suggests that neural stimulation might provide a source of which is important in generating or maintaining a Th-1 response, and in this way might be able to influence the nature of a local immune response in the skin. Such a pathway would also provide a potential mechanism for the long-described connection between neural influences and psoriasis. However, we would caution that a direct link has not yet been established, and that IL-12 staining patterns were similar in both normal and diseased skin. Nonetheless, our findings that IL-12 is contained within peripheral and central nervous tissue indicate that additional studies are warranted to determine whether targeting neuronal cells and their release of IL-12 will be of therapeutic value in inflammatory/ immune-mediated disorders.
